The Engineering and Science building from above. Researchers at the University of Connecticut have developed new tissue engineering technology that could help treat osteoarthritis. Photo by Eric ...
Hosted on MSN
Vivodyne Secures $40M Series A to Revolutionize Drug Discovery with Lab-Grown Human Tissues
SAN FRANCISCO, CA & PHILADELPHIA, PA — Vivodyne has raised $40 million in Series A funding to expand its cutting-edge robotics and AI platform, which uses lab-grown human tissues to transform ...
Tissue engineering via additive manufacturing—better known as 3D printing—is leaving the lab and making inroads in commercial applications. San Diego-based Organovo aims to improve both the in vitro ...
Andrei Georgescu, PhD, CEO of Vivodyne, was hoping to couple his interests in science and engineering when he chose UPenn for his graduate research. His goal was to build on his background in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback